XML 24 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net income $ 77,697 $ 38,332 $ 48,862
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 8,049 7,893 8,213
Net amortization of premiums on securities 5,493 3,474 2,069
(Benefit) provision for credit losses (8,336) 27,184 8,044
Share-based compensation 1,743 1,333 1,406
Deferred income tax expense (benefit) 5,218 (4,523) 369
Proceeds from sale of loans held for sale 81,334 97,238 41,479
Originations of loans held for sale (80,281) (93,461) (41,626)
Income on company owned life insurance (2,947) (1,902) (1,758)
Net gain on sale of loans held for sale (2,950) (3,858) (1,352)
Net gain on investment securities (71) (1,599) (1,677)
Net (gain) loss on other assets (441) 61 (29)
Noncash restructuring charges against assets 392 202 0
(Increase) decrease in other assets (9,342) (37,565) (21,263)
(Decrease) increase in other liabilities (2,596) 10,646 14,973
Net cash provided by operating activities 72,962 43,455 57,710
Cash flows from investing activities:      
Purchases of available for sale securities (784,064) (396,879) (195,660)
Purchases of held to maturity securities (18,425) (7,345) (23,494)
Proceeds from principal payments, maturities and calls on available for sale securities 150,919 97,685 82,358
Proceeds from principal payments, maturities and calls on held to maturity securities 83,684 93,046 83,508
Proceeds from sales of securities available for sale 51,891 107,098 178,059
Proceeds from sales of securities held to maturity 0 52 0
Net loan originations (90,058) (390,932) (167,234)
Loans sold to others 0 21,077
Purchases of company owned life insurance, net of proceeds received (20,056) (30,051) (68)
Proceeds from sales of other assets 3,510 519 360
Purchases of premises and equipment (9,403) (4,264) (3,639)
Cash consideration paid for acquisition, net of cash acquired (1,420)
Net cash used in investing activities (633,422) (531,071) (24,733)
Cash flows from financing activities:      
Net increase in deposits 548,723 722,692 188,768
Net increase (decrease) in short-term borrowings 24,700 (270,200) (194,000)
Repurchase of preferred stock (43)
Issuance of long-term debt, net of issuance costs 35,000
Debt issuance costs   (779)  
Purchases of common stock for treasury (9,235) (209) (293)
Cash dividends paid to preferred shareholders (1,460) (1,461) (1,461)
Cash dividends paid to common shareholders (16,991) (16,496) (15,799)
Net cash (used in) provided by financing activities 545,694 468,547 (22,785)
Net (decrease) increase in cash and cash equivalents (14,766) (19,069) 10,192
Cash and cash equivalents, beginning of period 93,878 112,947 102,755
Cash and cash equivalents, end of period $ 79,112 $ 93,878 $ 112,947